Acquisition Opportunity Biometics International was acquired by Pharma’s Almanac on Jan 1st 2010, indicating potential for legacy contracts, migration of customers, or integration projects with Pharma’s Almanac ecosystem to unlock cross sell of research services or subscription platforms.

Midmarket Biotech Operating with 11-50 employees in biotechnology research and revenue in the low single digits to under ten million, Biometics represents a midmarket target with needs for scalable lab software, data management, and cloud hosting solutions to support growing research programs.

Tech Stack Fit Current technologies include DreamWeaver, jQuery UI, Windows Server, and Microsoft IIS, suggesting opportunities for modernization services, frontend UX enhancements, and secure, compliant hosting or migration to modern stacks and cloud-based infrastructure.

Sustainability & Growth As a biotech research firm in North Carolina with a modest footprint, there may be interest in cost-effective, energy-efficient data center and hosting options, along with tools for grant tracking, collaboration, and IP management to support sustainable growth.

Competitive Positioning The company operates amid peers with varying scales; positioning Biometics to partner on analytics, credentialing, and reproducibility solutions could differentiate offerings and align with market trends toward standards-based research workflows.